Inhibition of High Mobility Group Box-1 (HMGB1) Eradicates Human Myelodysplastic Syndrome

MLA

Chad M. McCall, et al. “Inhibition of High Mobility Group Box-1 (HMGB1) Eradicates Human Myelodysplastic Syndrome.” Blood, vol. 132, Nov. 2018, p. 4348. EBSCOhost, https://doi.org/10.1182/blood-2018-99-119658.

APA

Chad M. McCall, Phuong L. Doan, Sadhna O. Piryani, Nelson J. Chao, Angel Y.F. Kam, & Hee Su Park. (2018). Inhibition of High Mobility Group Box-1 (HMGB1) Eradicates Human Myelodysplastic Syndrome. Blood, 132, 4348. https://doi.org/10.1182/blood-2018-99-119658

Chicago

Chad M. McCall, Phuong L. Doan, Sadhna O. Piryani, Nelson J. Chao, Angel Y.F. Kam, and Hee Su Park. 2018. “Inhibition of High Mobility Group Box-1 (HMGB1) Eradicates Human Myelodysplastic Syndrome.” Blood 132 (November): 4348. doi:10.1182/blood-2018-99-119658.